Skip to main content
Fig. 14 | BMC Cancer

Fig. 14

From: Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types

Fig. 14

Enrichment analysis of co-expressed genes with CD276 in glioblastoma using the LinkedOmics database. A Positively and negatively correlated genes of CD276 were differentiated using Pearson’s test in the LUAD cohort. B and C The heatmaps show the top 50 genes that were positively and negatively correlated with CD276, respectively. The positively correlated genes are shown in red, whereas negatively correlated genes are shown in blue. D and E GO and KEGG pathway analyses of CD276 in glioblastoma. F-I Enrichment analysis, showing that the expression of CD276 in glioblastoma was positively correlated with neutrophil-mediated immunity, whereas CD276 expression was negatively associated with regulation of neurotransmitter levels, neurotransmitter transport and neuropeptide signaling pathways

Back to article page